X
Please Wait
Applying Filters...
01 ABBVIE (3)
01 TABLET;ORAL (3)
01 DISCN (3)
01 MAVIK (3)
01 Yes (3)
78th STLE Annual Meeting
Not Confirmed
Contact Supplier78th STLE Annual Meeting
Not Confirmed
Contact Supplier78th STLE Annual Meeting
Not Confirmed
Contact Supplier19
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TRANDOLAPRIL, with a corresponding application number 20528.
Regulatory Information DISCN
With a dosage strength 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1996-04-26
18
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TRANDOLAPRIL, with a corresponding application number 20528.
Regulatory Information DISCN
With a dosage strength 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1996-04-26
17
AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TRANDOLAPRIL, with a corresponding application number 20528.
Regulatory Information DISCN
With a dosage strength 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 1996-04-26
Market Place
